Real-World Outcomes Among People Receiving Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Comparison between Those with and without Advanced HIV-1 Disease
Journal of Infection and Public Health · 2026-11 · 103413
DOI: 10.1016/j.jiph.2026.103413 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Infection and Public Health, 2026-11. Verfasst von Tsung-Yu Tsai und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
- Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
- Department of Critical Care Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Institute of Epidemiology and Preventive Medicine, College of Public Health, National, Taiwan University, Taipei, Taiwan; School of…
- Department of Internal Medicine, National Taiwan University Hospital Yunlin Branch, Yunlin, Taiwan.
- Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan; Department of Medicine, National Taiwan University Cancer Center, Taipei, Taiwan.
- Department of Internal Medicine, National Taiwan University Hospital Hsinchu Branch, Hsinchu, Taiwan; Department of Tropical Medicine and Parasitology, National Taiwan University College of Medicine, Taipei, Taiwan.
Zitieren
APA
Tsai, T. Y., Tsai, C. S., Chen, A. P., Chiu, P. W., Wu, T. Y., Liu, W. D., Huang, S. H., Lin, K. Y., & Hung, C. C. (2026). Real-World Outcomes Among People Receiving Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Comparison between Those with and without Advanced HIV-1 Disease. Journal of Infection and Public Health, 103413. https://doi.org/10.1016/j.jiph.2026.103413
Vancouver
Tsai TY, Tsai CS, Chen AP, Chiu PW, Wu TY, Liu WD, et al. Real-World Outcomes Among People Receiving Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Comparison between Those with and without Advanced HIV-1 Disease. Journal of Infection and Public Health. 2026:103413. doi:10.1016/j.jiph.2026.103413
BibTeX
@article{Tsai2026,
author = {Tsai, Tsung-Yu and Tsai, Chin-Shiang and Chen, Andrew Po-Liang and Chiu, Po-Wei and Wu, Tzong-Yow and Liu, Wang-Da and Huang, Sung-Hsi and Lin, Kuan-Yin and Hung, Chien-Ching},
title = {Real-World Outcomes Among People Receiving Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Comparison between Those with and without Advanced HIV-1 Disease},
journal = {Journal of Infection and Public Health},
year = {2026},
pages = {103413},
doi = {10.1016/j.jiph.2026.103413}
}
EUVIMED